A durable biocompatible artificial heart valve
Every year, more than half a million people undergo heart valve replacement surgery. However, available valves pose certain limitations and require lifelong anticoagulation therapy or replacement after 10 years. The EU-funded TRIFLO project has developed a unique valve made of high-performance biocompatible material that allows optimal blood flow, prevents the formation of clots and has great durability. The project will test the innovative valve in clinical trials and undertake the necessary activities towards its marketing. The clinical implementation of the valve will improve the quality of life of patients with valvular heart disease and reduce overall healthcare costs.
Call for proposal
See other projects for this call